Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost vs Travatan in open angle glaucoma or ocular hypertension
2010-022586-10Phase 3Active
- Sponsor
- Tiefenbacher
- Start
- Dec 2010
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of travoprost in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Tiefenbacher. Primary endpoint: Change in intraocular pressure from baseline to Day 42 in each period. Started Dec 2010; status: active.
02
Drugs
travoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2010-022586-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022586-10.